Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy/Experiment 28/Signature 2

From BugSigDB
Needs review

Curated date: 2024/11/11

Curator: KateRasheed

Revision editor(s): KateRasheed

Source: Additional file 12: Figure S12

Description: Differentially abundant taxa between the VANM group and HZ treatment group.

Abundance in Group 1: decreased abundance in HZ (H-Isoniazid, Z-Pyrazinamide)

NCBI Quality ControlLinks
Parabacteroides
Brenneria
Ruminiclostridium
Eubacteriales Family XIII. Incertae Sedis

Revision editor(s): KateRasheed